Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus

Summary Background  Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro‐oesophageal reflux disease (GERD). Aim  To assess the histological effects of esomeprazole treatment on the oesophagus. Methods  Data were derived from a subg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2006-01, Vol.23 (2), p.313-319
Hauptverfasser: VIETH, M., KULIG, M., LEODOLTER, A., NAUCLÉR, E., JASPERSEN, D., LABENZ, J., MEYER‐SABELLEK, W., LIND, T., WILLICH, S., MALFERTHEINER, P., STOLTE, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 319
container_issue 2
container_start_page 313
container_title Alimentary pharmacology & therapeutics
container_volume 23
creator VIETH, M.
KULIG, M.
LEODOLTER, A.
NAUCLÉR, E.
JASPERSEN, D.
LABENZ, J.
MEYER‐SABELLEK, W.
LIND, T.
WILLICH, S.
MALFERTHEINER, P.
STOLTE, M.
description Summary Background  Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro‐oesophageal reflux disease (GERD). Aim  To assess the histological effects of esomeprazole treatment on the oesophagus. Methods  Data were derived from a subgroup of patients participating in the proGERD study, who had either erosive reflux disease (n = 720) or non‐erosive reflux disease (n = 35) and who had biopsy data from two sites [(i) 2 cm above the z‐line and (ii) at the z‐line], obtained at baseline and following treatment with esomeprazole. Proliferative changes of the squamous epithelium were assessed histologically by measuring thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness. Results  In erosive reflux disease patients, the thickness of the basal cell layer and length of the papillae pretreatment were associated with the severity of oesophagitis (P 
doi_str_mv 10.1111/j.1365-2036.2006.02752.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67604486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20867575</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4782-e523ed5c61ccad4f485a6a11c62b58d593d6578e3c515e42ddf2add8227606603</originalsourceid><addsrcrecordid>eNqNkctOwzAQRS0EglL4BZQN7BL8iB9dsKgqXlIlWJS1ce1JSZXUadwIytfj0AqW4I3HmnOvR3cQSgjOSDzXy4wwwVOKmcgoxiLDVHKafRygwU_jEA0wFaOUKsJO0GkISxxJiekxOiGCjRgjdIBeH8qw8ZVflNZUCRQF2E1IfJFA8DU0rfn0FSSbN2hNs038qi-TsO5M7buQQFPGd1V2dS_pWy7aRSMf5c2bWXThDB0Vpgpwvr-H6OXudjZ5SKdP94-T8TS1uVQ0BU4ZOG4Fsda4vMgVN8IQYgWdc-X4iDnBpQJmOeGQU-cKapxTlEqBhcBsiK52vk3r1x2Eja7LYKGqzAriqFpELs-V-BOkWAnJJY-g2oG29SG0UOimLWvTbjXBul-DXuo-bd2nrfs16O816I8ovdj_0c1rcL_Cfe4RuNwDJsTgi9asbBl-ORlDYSMZuZsd915WsP33AHr8POsr9gXKdaQf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20867575</pqid></control><display><type>article</type><title>Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>VIETH, M. ; KULIG, M. ; LEODOLTER, A. ; NAUCLÉR, E. ; JASPERSEN, D. ; LABENZ, J. ; MEYER‐SABELLEK, W. ; LIND, T. ; WILLICH, S. ; MALFERTHEINER, P. ; STOLTE, M.</creator><creatorcontrib>VIETH, M. ; KULIG, M. ; LEODOLTER, A. ; NAUCLÉR, E. ; JASPERSEN, D. ; LABENZ, J. ; MEYER‐SABELLEK, W. ; LIND, T. ; WILLICH, S. ; MALFERTHEINER, P. ; STOLTE, M.</creatorcontrib><description>Summary Background  Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro‐oesophageal reflux disease (GERD). Aim  To assess the histological effects of esomeprazole treatment on the oesophagus. Methods  Data were derived from a subgroup of patients participating in the proGERD study, who had either erosive reflux disease (n = 720) or non‐erosive reflux disease (n = 35) and who had biopsy data from two sites [(i) 2 cm above the z‐line and (ii) at the z‐line], obtained at baseline and following treatment with esomeprazole. Proliferative changes of the squamous epithelium were assessed histologically by measuring thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness. Results  In erosive reflux disease patients, the thickness of the basal cell layer and length of the papillae pretreatment were associated with the severity of oesophagitis (P &lt; 0.05), at both biopsy sites. After esomeprazole treatment, baseline thickness and length of papillae were significantly reduced (P &lt; 0.05) at both biopsy sites in non‐erosive reflux disease and erosive reflux disease patients (particularly those with Los Angeles grades C and D). Conclusion  This demonstrates a strong correlation between severity of GERD and histological parameters. Esomeprazole therapy resulted in clear reversal of proliferative changes observed prior to treatment in the squamous epithelium at both biopsy locations.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2006.02752.x</identifier><identifier>PMID: 16393312</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adult ; Biological and medical sciences ; Biopsy - methods ; Cell Division - drug effects ; Digestive system ; Enzyme Inhibitors - therapeutic use ; Epithelial Cells - drug effects ; Epithelial Cells - pathology ; Epithelium - drug effects ; Epithelium - pathology ; Esomeprazole - therapeutic use ; Esophagitis, Peptic - drug therapy ; Esophagitis, Peptic - pathology ; Esophagoscopy - methods ; Esophagus - drug effects ; Esophagus - pathology ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gastroesophageal Reflux - drug therapy ; Gastroesophageal Reflux - pathology ; Humans ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Prospective Studies ; Treatment Outcome</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2006-01, Vol.23 (2), p.313-319</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4782-e523ed5c61ccad4f485a6a11c62b58d593d6578e3c515e42ddf2add8227606603</citedby><cites>FETCH-LOGICAL-c4782-e523ed5c61ccad4f485a6a11c62b58d593d6578e3c515e42ddf2add8227606603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2036.2006.02752.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2036.2006.02752.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17478397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16393312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VIETH, M.</creatorcontrib><creatorcontrib>KULIG, M.</creatorcontrib><creatorcontrib>LEODOLTER, A.</creatorcontrib><creatorcontrib>NAUCLÉR, E.</creatorcontrib><creatorcontrib>JASPERSEN, D.</creatorcontrib><creatorcontrib>LABENZ, J.</creatorcontrib><creatorcontrib>MEYER‐SABELLEK, W.</creatorcontrib><creatorcontrib>LIND, T.</creatorcontrib><creatorcontrib>WILLICH, S.</creatorcontrib><creatorcontrib>MALFERTHEINER, P.</creatorcontrib><creatorcontrib>STOLTE, M.</creatorcontrib><title>Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary Background  Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro‐oesophageal reflux disease (GERD). Aim  To assess the histological effects of esomeprazole treatment on the oesophagus. Methods  Data were derived from a subgroup of patients participating in the proGERD study, who had either erosive reflux disease (n = 720) or non‐erosive reflux disease (n = 35) and who had biopsy data from two sites [(i) 2 cm above the z‐line and (ii) at the z‐line], obtained at baseline and following treatment with esomeprazole. Proliferative changes of the squamous epithelium were assessed histologically by measuring thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness. Results  In erosive reflux disease patients, the thickness of the basal cell layer and length of the papillae pretreatment were associated with the severity of oesophagitis (P &lt; 0.05), at both biopsy sites. After esomeprazole treatment, baseline thickness and length of papillae were significantly reduced (P &lt; 0.05) at both biopsy sites in non‐erosive reflux disease and erosive reflux disease patients (particularly those with Los Angeles grades C and D). Conclusion  This demonstrates a strong correlation between severity of GERD and histological parameters. Esomeprazole therapy resulted in clear reversal of proliferative changes observed prior to treatment in the squamous epithelium at both biopsy locations.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Biopsy - methods</subject><subject>Cell Division - drug effects</subject><subject>Digestive system</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - pathology</subject><subject>Epithelium - drug effects</subject><subject>Epithelium - pathology</subject><subject>Esomeprazole - therapeutic use</subject><subject>Esophagitis, Peptic - drug therapy</subject><subject>Esophagitis, Peptic - pathology</subject><subject>Esophagoscopy - methods</subject><subject>Esophagus - drug effects</subject><subject>Esophagus - pathology</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gastroesophageal Reflux - drug therapy</subject><subject>Gastroesophageal Reflux - pathology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkctOwzAQRS0EglL4BZQN7BL8iB9dsKgqXlIlWJS1ce1JSZXUadwIytfj0AqW4I3HmnOvR3cQSgjOSDzXy4wwwVOKmcgoxiLDVHKafRygwU_jEA0wFaOUKsJO0GkISxxJiekxOiGCjRgjdIBeH8qw8ZVflNZUCRQF2E1IfJFA8DU0rfn0FSSbN2hNs038qi-TsO5M7buQQFPGd1V2dS_pWy7aRSMf5c2bWXThDB0Vpgpwvr-H6OXudjZ5SKdP94-T8TS1uVQ0BU4ZOG4Fsda4vMgVN8IQYgWdc-X4iDnBpQJmOeGQU-cKapxTlEqBhcBsiK52vk3r1x2Eja7LYKGqzAriqFpELs-V-BOkWAnJJY-g2oG29SG0UOimLWvTbjXBul-DXuo-bd2nrfs16O816I8ovdj_0c1rcL_Cfe4RuNwDJsTgi9asbBl-ORlDYSMZuZsd915WsP33AHr8POsr9gXKdaQf</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>VIETH, M.</creator><creator>KULIG, M.</creator><creator>LEODOLTER, A.</creator><creator>NAUCLÉR, E.</creator><creator>JASPERSEN, D.</creator><creator>LABENZ, J.</creator><creator>MEYER‐SABELLEK, W.</creator><creator>LIND, T.</creator><creator>WILLICH, S.</creator><creator>MALFERTHEINER, P.</creator><creator>STOLTE, M.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200601</creationdate><title>Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus</title><author>VIETH, M. ; KULIG, M. ; LEODOLTER, A. ; NAUCLÉR, E. ; JASPERSEN, D. ; LABENZ, J. ; MEYER‐SABELLEK, W. ; LIND, T. ; WILLICH, S. ; MALFERTHEINER, P. ; STOLTE, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4782-e523ed5c61ccad4f485a6a11c62b58d593d6578e3c515e42ddf2add8227606603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Biopsy - methods</topic><topic>Cell Division - drug effects</topic><topic>Digestive system</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - pathology</topic><topic>Epithelium - drug effects</topic><topic>Epithelium - pathology</topic><topic>Esomeprazole - therapeutic use</topic><topic>Esophagitis, Peptic - drug therapy</topic><topic>Esophagitis, Peptic - pathology</topic><topic>Esophagoscopy - methods</topic><topic>Esophagus - drug effects</topic><topic>Esophagus - pathology</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gastroesophageal Reflux - drug therapy</topic><topic>Gastroesophageal Reflux - pathology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VIETH, M.</creatorcontrib><creatorcontrib>KULIG, M.</creatorcontrib><creatorcontrib>LEODOLTER, A.</creatorcontrib><creatorcontrib>NAUCLÉR, E.</creatorcontrib><creatorcontrib>JASPERSEN, D.</creatorcontrib><creatorcontrib>LABENZ, J.</creatorcontrib><creatorcontrib>MEYER‐SABELLEK, W.</creatorcontrib><creatorcontrib>LIND, T.</creatorcontrib><creatorcontrib>WILLICH, S.</creatorcontrib><creatorcontrib>MALFERTHEINER, P.</creatorcontrib><creatorcontrib>STOLTE, M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VIETH, M.</au><au>KULIG, M.</au><au>LEODOLTER, A.</au><au>NAUCLÉR, E.</au><au>JASPERSEN, D.</au><au>LABENZ, J.</au><au>MEYER‐SABELLEK, W.</au><au>LIND, T.</au><au>WILLICH, S.</au><au>MALFERTHEINER, P.</au><au>STOLTE, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2006-01</date><risdate>2006</risdate><volume>23</volume><issue>2</issue><spage>313</spage><epage>319</epage><pages>313-319</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Summary Background  Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro‐oesophageal reflux disease (GERD). Aim  To assess the histological effects of esomeprazole treatment on the oesophagus. Methods  Data were derived from a subgroup of patients participating in the proGERD study, who had either erosive reflux disease (n = 720) or non‐erosive reflux disease (n = 35) and who had biopsy data from two sites [(i) 2 cm above the z‐line and (ii) at the z‐line], obtained at baseline and following treatment with esomeprazole. Proliferative changes of the squamous epithelium were assessed histologically by measuring thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness. Results  In erosive reflux disease patients, the thickness of the basal cell layer and length of the papillae pretreatment were associated with the severity of oesophagitis (P &lt; 0.05), at both biopsy sites. After esomeprazole treatment, baseline thickness and length of papillae were significantly reduced (P &lt; 0.05) at both biopsy sites in non‐erosive reflux disease and erosive reflux disease patients (particularly those with Los Angeles grades C and D). Conclusion  This demonstrates a strong correlation between severity of GERD and histological parameters. Esomeprazole therapy resulted in clear reversal of proliferative changes observed prior to treatment in the squamous epithelium at both biopsy locations.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>16393312</pmid><doi>10.1111/j.1365-2036.2006.02752.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2006-01, Vol.23 (2), p.313-319
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_67604486
source MEDLINE; Access via Wiley Online Library; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection)
subjects Adult
Biological and medical sciences
Biopsy - methods
Cell Division - drug effects
Digestive system
Enzyme Inhibitors - therapeutic use
Epithelial Cells - drug effects
Epithelial Cells - pathology
Epithelium - drug effects
Epithelium - pathology
Esomeprazole - therapeutic use
Esophagitis, Peptic - drug therapy
Esophagitis, Peptic - pathology
Esophagoscopy - methods
Esophagus - drug effects
Esophagus - pathology
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gastroesophageal Reflux - drug therapy
Gastroesophageal Reflux - pathology
Humans
Male
Medical sciences
Pharmacology. Drug treatments
Prospective Studies
Treatment Outcome
title Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T02%3A40%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histological%20effects%20of%20esomeprazole%20therapy%20on%20the%20squamous%20epithelium%20of%20the%20distal%20oesophagus&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=VIETH,%20M.&rft.date=2006-01&rft.volume=23&rft.issue=2&rft.spage=313&rft.epage=319&rft.pages=313-319&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2006.02752.x&rft_dat=%3Cproquest_cross%3E20867575%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20867575&rft_id=info:pmid/16393312&rfr_iscdi=true